We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGR
1276
DELISTED
Vector Group Ltd.
VGR
$607K 0.01%
85,027
+20,477
+32% +$156K
FFBC icon
1277
First Financial Bancorp
FFBC
$3.6B
$606K 0.01%
43,646
CWK icon
1278
Cushman & Wakefield Ltd
CWK
$3.37B
$605K 0.01%
48,568
JRVR icon
1279
James River Group Holdings
JRVR
$200M
$603K 0.01%
13,410
KN icon
1280
Knowles
KN
$3.23B
$601K 0.01%
39,393
+4,252
+12% +$63.4K
NAV
1281
DELISTED
Navistar International
NAV
$600K 0.01%
21,262
SILK
1282
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$598K 0.01%
14,280
+6,812
+91% +$262K
MINI
1283
DELISTED
Mobile Mini Inc
MINI
$597K 0.01%
20,245
FIBK icon
1284
First Interstate BancSystem
FIBK
$3.7B
$597K 0.01%
19,271
+2,332
+14% +$71.2K
SDGR icon
1285
Schrodinger
SDGR
$1.38B
$596K 0.01%
6,513
KPTI icon
1286
Karyopharm Therapeutics
KPTI
$45.1M
$596K 0.01%
2,099
+383
+22% +$113K
UPWK icon
1287
Upwork
UPWK
$1.08B
$596K 0.01%
41,283
+16,436
+66% +$173K
LZB icon
1288
La-Z-Boy
LZB
$1.67B
$594K 0.01%
21,955
+3,320
+18% +$79.8K
UPBD icon
1289
Upbound Group
UPBD
$1.15B
$592K 0.01%
21,277
THRM icon
1290
Gentherm
THRM
$1.32B
$590K 0.01%
15,174
CDE icon
1291
Coeur Mining
CDE
$19B
$588K 0.01%
115,698
+18,493
+19% +$84.1K
EPRT icon
1292
Essential Properties Realty Trust
EPRT
$6.71B
$587K 0.01%
39,544
OPK icon
1293
Opko Health
OPK
$1.04B
$587K 0.01%
171,997
ATSG
1294
DELISTED
Air Transport Services Group
ATSG
$586K 0.01%
26,334
+2,012
+8% +$41.2K
CPK icon
1295
Chesapeake Utilities
CPK
$3.26B
$586K 0.01%
6,975
HTLF
1296
DELISTED
Heartland Financial USA, Inc.
HTLF
$584K 0.01%
17,478
+2,650
+18% +$82.9K
BBBY
1297
DELISTED
Bed Bath & Beyond Inc
BBBY
$584K 0.01%
55,063
-72,650
-57% -$500K
NBTB icon
1298
NBT Bancorp
NBTB
$2.79B
$582K 0.01%
18,936
+1,466
+8% +$45.7K
YMAB
1299
DELISTED
Y-mAbs Therapeutics
YMAB
$580K 0.01%
13,415
+3,344
+33% +$126K
DK icon
1300
Delek US
DK
$4.18B
$580K 0.01%
33,286

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.